Boris I Chobrutskiy1, Saif Zaman1, Wei Lue Tong1, Andrea Diviney1, George Blanck2,3. 1. Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901, Bruce B. Downs Bd. MDC7, Tampa, FL, 33612, USA. 2. Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901, Bruce B. Downs Bd. MDC7, Tampa, FL, 33612, USA. gblanck@health.usf.edu. 3. Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA. gblanck@health.usf.edu.
Abstract
BACKGROUND: The immune system plays an important role in cancer survival and disease progression, but the role of the immune system in lower grade glioma (LGG) is largely unknown METHODS: To investigate the relationship between lymphocyte infiltration into the LGG microenvironment and LGG survival, we used a genomics approach to recover productive V(D)J recombination sequences from primary tumor, whole exome sequence files available via the cancer genome atlas RESULTS: Increased T-cell receptor V(D)J read recovery, indicating increased T-lymphocyte infiltration into the primary tumor site, strongly correlated with decreased overall and disease-free survival; and with a more advanced cancer grade. In addition, this result was more significant than related results obtainable using RNASeq-based, T-cell biomarkers, similar to a recently reported case for pancreatic cancer, where the recovery of BCR recombination reads from WXS files clearly associated with reduced survival, despite the fact that no such association was demonstrable with B-cell based, RNASeq biomarkers CONCLUSIONS: Overall, the results presented here support V(D)J recombination read recovery, from whole exome files, as a uniquely useful biomarker for distinct LGG survival rates.
BACKGROUND: The immune system plays an important role in cancer survival and disease progression, but the role of the immune system in lower grade glioma (LGG) is largely unknown METHODS: To investigate the relationship between lymphocyte infiltration into the LGG microenvironment and LGG survival, we used a genomics approach to recover productive V(D)J recombination sequences from primary tumor, whole exome sequence files available via the cancer genome atlas RESULTS: Increased T-cell receptor V(D)J read recovery, indicating increased T-lymphocyte infiltration into the primary tumor site, strongly correlated with decreased overall and disease-free survival; and with a more advanced cancer grade. In addition, this result was more significant than related results obtainable using RNASeq-based, T-cell biomarkers, similar to a recently reported case for pancreatic cancer, where the recovery of BCR recombination reads from WXS files clearly associated with reduced survival, despite the fact that no such association was demonstrable with B-cell based, RNASeq biomarkers CONCLUSIONS: Overall, the results presented here support V(D)J recombination read recovery, from whole exome files, as a uniquely useful biomarker for distinct LGG survival rates.
Entities:
Keywords:
Immune biomarkers; Lower grade glioblastoma exomes; Recombination reads; Survival rates; T-lymphocyte infiltrates; The cancer genome atlas
Authors: Blake M Callahan; John M Yavorski; Yaping N Tu; Wei Lue Tong; Jacob C Kinskey; Kendall R Clark; Timothy J Fawcett; George Blanck Journal: Cancer Immunol Immunother Date: 2018-03-05 Impact factor: 6.968
Authors: Jennifer S Sims; Boris Grinshpun; Yaping Feng; Timothy H Ung; Justin A Neira; Jorge L Samanamud; Peter Canoll; Yufeng Shen; Peter A Sims; Jeffrey N Bruce Journal: Proc Natl Acad Sci U S A Date: 2016-06-03 Impact factor: 11.205
Authors: Lijie Zhai; Erik Ladomersky; Kristen L Lauing; Meijing Wu; Matthew Genet; Galina Gritsina; Balázs Győrffy; Priscilla K Brastianos; David C Binder; Jeffrey A Sosman; Francis J Giles; Charles D James; Craig Horbinski; Roger Stupp; Derek A Wainwright Journal: Clin Cancer Res Date: 2017-07-27 Impact factor: 12.531
Authors: Bo Li; Taiwen Li; Jean-Christophe Pignon; Binbin Wang; Jinzeng Wang; Sachet A Shukla; Ruoxu Dou; Qianming Chen; F Stephen Hodi; Toni K Choueiri; Catherine Wu; Nir Hacohen; Sabina Signoretti; Jun S Liu; X Shirley Liu Journal: Nat Genet Date: 2016-05-30 Impact factor: 38.330
Authors: Andrea Chobrutskiy; Boris I Chobrutskiy; Saif Zaman; Monica Hsiang; George Blanck Journal: Breast Cancer Res Treat Date: 2020-11-12 Impact factor: 4.872
Authors: Brandon J Manley; Philipp M Altrock; Meghan C Ferrall-Fairbanks; Nicholas H Chakiryan; Boris I Chobrutskiy; Youngchul Kim; Jamie K Teer; Anders Berglund; James J Mulé; Michelle Fournier; Erin M Siegel; Jasreman Dhillon; Seyed Shayan A Falasiri; Juan F Arturo; Esther N Katende; George Blanck Journal: Cancer Res Date: 2022-03-01 Impact factor: 12.701
Authors: Brooke E Mcbreairty; Boris I Chobrutskiy; Andrea Chobrutskiy; Etienne C Gozlan; Michael J Diaz; George Blanck Journal: Biomed Rep Date: 2022-06-09
Authors: Jacqueline Wahura Waweru; Kennedy Wanjau Mwangi; Vayda R Barker; Etienne C Gozlan; Michelle Yeagley; George Blanck; Francis W Makokha Journal: J Cancer Res Clin Oncol Date: 2022-09-13 Impact factor: 4.322
Authors: Boris I Chobrutskiy; Michelle Yeagley; Andrea Diviney; Saif Zaman; Etienne C Gozlan; Price Tipping; Darush M Koohestani; Andrea M Roca; George Blanck Journal: Immunology Date: 2020-01-21 Impact factor: 7.397
Authors: Etienne C Gozlan; Boris I Chobrutskiy; Saif Zaman; Michelle Yeagley; George Blanck Journal: J Mol Neurosci Date: 2021-03-05 Impact factor: 3.444